InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Other Events

Item8.01 Other Events.

On April14, 2017, InfuSystem Holdings, Inc. issued a press
release announcing that the Company will hold its 2017 Annual
Meeting of Stockholders on June22, 2017 at 10:00 a.m. Eastern
Time at the Companys offices at 11130 Strang Line Rd., Lenexa,
Kansas 66215. A copy of the press release is furnished as an
exhibit to this Form 8-K.

Because the expected date of the 2017 Annual Meeting represents a
change of more than 30 days from the anniversary of the Companys
2016 annual stockholders meeting, the Company has set a new
deadline for the receipt of stockholder proposals submitted to
Rule 14a-8 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), for inclusion in the Companys proxy materials
for the 2017 Annual Meeting. To be considered for inclusion, such
proposals must be received in writing by the Company before the
close of business on April 24, 2017.

Proposals must also comply with the applicable requirements of
Rule 14a-8 of the Exchange Act regarding the inclusion of
stockholder proposals in Company-sponsored proxy materials and
other applicable laws. The April 24, 2017 deadline will also
apply in determining whether notice of a stockholder proposal is
timely for purposes of exercising discretionary voting authority
with respect to proxies under Rule 14a-4(c)(1) of the Exchange
Act.

Additionally, for a stockholder to bring business before the 2017
Annual Meeting outside of Rule 14a-8 of the Exchange Act or to
nominate a director, it must provide timely notice within the
applicable time period set forth in the advance notice provisions
of the Companys Bylaws (the Bylaws). The Bylaws provide that the
Secretary of the Company must receive written notice at the
principal executive offices of the Company no later than 60 days
(April 23, 2017) prior to the meeting date or 10 days (April24,
2017) following the announcement of the meeting date and the
stockholder must otherwise comply with the requirements set forth
in the Bylaws.

Any stockholder proposal for inclusion in the Companys proxy
materials, notice of proposed business to be brought before the
2017 Annual Meeting, or director nomination should be sent to the
Companys Secretary at the Companys principal executive offices
located at 11130 Strang Line Rd., Lenexa, Kansas 66215.

(a) Financial statements:

None

(b) Pro forma financial information:

None

(c) Shell company transactions:

None

(d) Exhibits

About InfuSystem Holdings, Inc. (NYSEMKT:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

InfuSystem Holdings, Inc. (NYSEMKT:INFU) Recent Trading Information

InfuSystem Holdings, Inc. (NYSEMKT:INFU) closed its last trading session down -0.02 at 2.15 with 18,277 shares trading hands.